Join Arent Fox LLP for a free lunch program that will address the convergence of medicine and the Internet of Things. BioDirection’s latest groundbreaking medical device designed to aid in the early diagnosis of concussions will be used as an example of how the life sciences industry is focusing on a “Smart” future of point of care. You will learn about the technology behind BioDirection’s Tbit™ System, as well as the software developed to provide secure and compliant data aggregation. You will also hear advice and suggestions from the venture capital and legal regulatory perspectives, regarding funding strategies and FDA compliance.
• Sharad Joshi, President & CEO, BioDirection, Inc.
• Navin Dewagan, President, Digital Health Solutions, LLC
• Bret Siarkowski, Managing Partner, MedScience Ventures, LLC
• Deborah Shelton, Partner, Arent Fox LLP
RSVPs required by October 8th. Space is limited